Forest Continues To Bank On Growth Of its Savella Medication for Fibromyalgia
This article was originally published in The Pink Sheet Daily
Executive Summary
With the only drug indicated solely for fibromyalgia, Forest expects Savella to help offset declining sales from its Lexapro antidepressant.